Minerva Neurosciences Stock Filter Stocks by Fundamentals
| NERV Stock | USD 2.55 0.07 2.82% |
Minerva Neurosciences fundamentals help investors to digest information that contributes to Minerva Neurosciences' financial success or failures. It also enables traders to predict the movement of Minerva Stock. The fundamental analysis module provides a way to measure Minerva Neurosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Minerva Neurosciences stock.
Minerva | Shares Owned by Institutions |
Minerva Neurosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Minerva Neurosciences from analyzing Minerva Neurosciences' financial statements. These drivers represent accounts that assess Minerva Neurosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Minerva Neurosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 277.4M | 95.5M | 34.2M | 8.5M | 40.0M | 38.0M | |
| Enterprise Value | 256.3M | 70.3M | (26.5M) | 46.1M | 81.0M | 127.3M |
Minerva Neurosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Minerva Neurosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Minerva Neurosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Minerva Neurosciences' value.| Shares | Wells Fargo & Co | 2023-12-31 | 2 K | Tower Research Capital Llc | 2023-12-31 | 1.4 K | Royal Bank Of Canada | 2023-12-31 | 494 | Tfc Financial Management | 2023-12-31 | 186 | Bank Of America Corp | 2023-12-31 | 128 | Northwestern Mutual Wealth Management Co | 2023-12-31 | 100.0 | Ubs Group Ag | 2023-12-31 | 65.0 | Anchor Investment Management Llc | 2023-12-31 | 12.0 | Susquehanna International Group, Llp | 2023-12-31 | 0.0 | Federated Hermes Inc | 2023-12-31 | 1.4 M | Fmr Inc | 2023-12-31 | 491.7 K |
Minerva Fundamentals
| Return On Equity | -6.75 | ||||
| Return On Asset | -0.26 | ||||
| Current Valuation | 58.45 M | ||||
| Shares Outstanding | 6.99 M | ||||
| Shares Owned By Insiders | 22.26 % | ||||
| Shares Owned By Institutions | 35.10 % | ||||
| Number Of Shares Shorted | 40.31 K | ||||
| Price To Earning | 69.58 X | ||||
| Price To Book | 2.68 X | ||||
| Price To Sales | 1.87 X | ||||
| Gross Profit | (16.84 M) | ||||
| EBITDA | (23.09 M) | ||||
| Net Income | (30.01 M) | ||||
| Cash And Equivalents | 40.22 M | ||||
| Cash Per Share | 7.53 X | ||||
| Total Debt | 82.02 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 20.41 X | ||||
| Book Value Per Share | (4.07) X | ||||
| Cash Flow From Operations | (14.78 M) | ||||
| Short Ratio | 0.31 X | ||||
| Earnings Per Share | (4.61) X | ||||
| Target Price | 11.0 | ||||
| Beta | 0.22 | ||||
| Market Capitalization | 17.34 M | ||||
| Total Asset | 56.9 M | ||||
| Retained Earnings | (396.82 M) | ||||
| Working Capital | 38.66 M | ||||
| Current Asset | 33.48 M | ||||
| Current Liabilities | 5.32 M | ||||
| Net Asset | 56.9 M |
About Minerva Neurosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Minerva Neurosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Minerva Neurosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Minerva Neurosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Minerva Neurosciences Piotroski F Score and Minerva Neurosciences Altman Z Score analysis. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Minerva Stock analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.61) | Return On Assets (0.26) | Return On Equity (6.75) |
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.